Question 75

Taking both prasugrel and aspirin for post-myocardial infarction care increases the risk of severe bleeding.

The combination of prasugrel and aspirin is known to enhance antiplatelet effects, which can significantly elevate the risk of severe bleeding complications in patients who do not undergo appropriate therapeutic monitoring.

A) Toxic epidermal necrolysis

Toxic epidermal necrolysis is a severe skin condition that is generally linked to drug reactions, particularly antibiotics and anticonvulsants, rather than the antiplatelet therapy involving prasugrel and aspirin. Therefore, while it is a serious condition, it is not directly related to the risks associated with combining these medications.

B) Photosensitivity

Photosensitivity is an adverse reaction that can occur with certain medications, but it is not a recognized risk associated with prasugrel and aspirin. This side effect is more common with other types of drugs, such as some antibiotics and diuretics, making this option incorrect in the context of the question.

C) Severe bleeding

The use of both prasugrel and aspirin increases the risk of severe bleeding due to their combined antiplatelet effects. Without proper monitoring, patients may experience significant hemorrhagic complications, which is a critical risk in post-myocardial infarction care.

D) Dehydration

Dehydration is generally caused by factors such as inadequate fluid intake, excessive fluid loss, or certain medical conditions, rather than the direct effects of prasugrel and aspirin. It is not a typical concern related to the antiplatelet therapy in the context provided, making this option incorrect.

Conclusion

Severe bleeding is a well-documented risk when using prasugrel and aspirin together without appropriate therapeutic monitoring. The other options, including toxic epidermal necrolysis, photosensitivity, and dehydration, do not have a direct correlation with the effects of these medications, thereby confirming that C is the only correct answer in this scenario.